Jpmorgan Chase & CO Hille Vax, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Hille Vax, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 48,016 shares of HLVX stock, worth $99,873. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48,016
Previous 207,151 76.82%
Holding current value
$99,873
Previous $422,000 83.65%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
SELL
$1.45 - $2.14 $230,745 - $340,548
-159,135 Reduced 76.82%
48,016 $69,000
Q4 2024

Feb 12, 2025
BUY
$1.72 - $2.06 $332,173 - $397,835
193,124 Added 1376.8%
207,151 $422,000
Q3 2024

Dec 26, 2024
SELL
$1.58 - $14.42 $30,612 - $279,387
-19,375 Reduced 58.01%
14,027 $24,000
Q3 2024

Nov 08, 2024
SELL
$1.58 - $14.42 $30,612 - $279,387
-19,375 Reduced 58.01%
14,027 $24,000
Q2 2024

Dec 26, 2024
BUY
$11.86 - $15.93 $229,787 - $308,643
19,375 Added 138.13%
33,402 $482,000
Q2 2024

Aug 12, 2024
SELL
$11.86 - $15.93 $162,126 - $217,763
-13,670 Reduced 29.04%
33,402 $482,000
Q1 2024

Dec 26, 2024
BUY
$14.15 - $19.75 $467,586 - $652,638
33,045 Added 235.58%
47,072 $782,000
Q1 2024

May 10, 2024
BUY
$14.15 - $19.75 $420,679 - $587,167
29,730 Added 171.43%
47,072 $782,000
Q4 2023

Dec 26, 2024
BUY
$10.35 - $17.11 $34,310 - $56,719
3,315 Added 23.63%
17,342 $278,000
Q4 2023

Feb 12, 2024
SELL
$10.35 - $17.11 $47,672 - $78,808
-4,606 Reduced 20.99%
17,342 $278,000
Q3 2023

Nov 14, 2023
BUY
$11.59 - $16.7 $49,014 - $70,624
4,229 Added 23.87%
21,948 $295,000
Q2 2023

Aug 11, 2023
BUY
$12.93 - $18.76 $36,333 - $52,715
2,810 Added 18.85%
17,719 $304,000
Q1 2023

May 18, 2023
BUY
$14.73 - $18.18 $196,984 - $243,121
13,373 Added 870.64%
14,909 $246,000
Q1 2023

May 11, 2023
SELL
$14.73 - $18.18 $144,530 - $178,382
-9,812 Reduced 86.46%
1,536 $25,000
Q4 2022

Feb 13, 2023
BUY
$13.52 - $21.46 $57,676 - $91,548
4,266 Added 60.24%
11,348 $190,000
Q3 2022

Nov 14, 2022
BUY
$10.5 - $22.01 $1,606 - $3,367
153 Added 2.21%
7,082 $121,000
Q2 2022

Aug 11, 2022
BUY
$8.7 - $20.18 $60,282 - $139,827
6,929 New
6,929 $76,000

Others Institutions Holding HLVX

# of Institutions
74
Shares Held
36.1M
Call Options Held
0
Put Options Held
0
View Full List

About HilleVax, Inc.

HLVX Quotes by TradingView
  • Ticker HLVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,427,200
  • Market Cap $69.5M
  • Description
  • HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
More about HLVX
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email